RPRX – royalty pharma plc - class a ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RPRX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/30

06:01 am

rprx

Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.

Low Report

Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.

Report

1/30

04:40 am

rprx

Royalty Pharma upgraded to Buy from Neutral at UBS

Low Report

Royalty Pharma upgraded to Buy from Neutral at UBS

Report

1/27

09:39 am

rprx

Rating for RPRX

Low Report

Rating for RPRX

Report

1/27

09:39 am

rprx

Rating for RPRX

Low Report

Rating for RPRX

Report

1/27

07:19 am

rprx

Royalty Pharma (NASDAQ:RPRX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..

Low Report

Royalty Pharma (NASDAQ:RPRX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.